Virpax Pharmaceuticals, Inc. (NASDAQ:VRPX)

DEVELOPING DIFFERENTIATED TREATMENT OPTIONS THAT ADDRESS UNMET GLOBAL NEEDS IN MULTI-BILLION DOLLAR MARKETS. REVIEW OUR TRANSFORMING DRUG-DELIVERY PLATFORMS.

Virpax® Pharmaceuticals Inc., (Nasdaq: VRPX) is a publicly held specialty pharmaceutical company located in Berwyn, PA and is focused on advancing the development and worldwide commercialization of its non-addictive pain and neurological disorder pipeline.

Virpax’s transforming drug-delivery platforms and their targeted drug-releasing capabilities have been developed to enhance compliance and to optimize the efficacy of our non-addictive pain management pipeline and our Central Nervous System (CNS) disorder pipeline.

Virpax’s non-addictive pain management pipeline is being developed to provide prescribers more treatment options to help individualized patient care. Once approved, these pain management alternatives may help patients achieve better health outcomes.
https://virpaxpharma.com/